The SYGALAF brand, founded in 2013 (Japan), from 440 sister brands and 4958 competing brands. The SYGALAF brand is owned by Takeda Pharmaceutical, a company listed in Francfort. The International Securities Identification Number (ISIN) of Takeda Pharmaceutical is JP3463000004. SYGALAF belongs to the Drug Manufacturers business sector.